Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

The drug combination was safe and showed promise in treating advanced tumors.

miR-200c-3p could help diagnose and treat alopecia areata.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

CXCR2 in skin cells promotes tumor growth.

The assay effectively identifies compounds that affect immune cell activation.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Yangxuebushen Decoction helps prevent hair loss from chemotherapy.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

A specific group of skin stem cells was found to help maintain hair follicle cells.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

PDCD4 is important for controlling skin cell growth and healing.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.